Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres

Purpose To evaluate a new chronic glaucoma model produced by intracameral injection of dexamethasone-loaded poly lactic-co-glycolic acid microspheres (Dex-PLGA-Ms) over six months. Methods Healthy rats received two injections (at baseline and Week 4) of Dex-PLGA-Ms into the anterior chamber of the r...

Full description

Bibliographic Details
Main Authors: MJ Rodrigo, D Garcia-Herranz, A Aragón-Navas, M Subias, T Martinez-Rincón, S Mendez-Martínez, MJ Cardiel, J García-Feijoo, J Ruberte, R Herrero-Vanrell, L Pablo, E Garcia-Martin, I Bravo-Osuna
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Drug Delivery
Subjects:
Online Access:http://dx.doi.org/10.1080/10717544.2021.1998245
_version_ 1818979853033013248
author MJ Rodrigo
D Garcia-Herranz
A Aragón-Navas
M Subias
T Martinez-Rincón
S Mendez-Martínez
MJ Cardiel
J García-Feijoo
J Ruberte
R Herrero-Vanrell
L Pablo
E Garcia-Martin
I Bravo-Osuna
author_facet MJ Rodrigo
D Garcia-Herranz
A Aragón-Navas
M Subias
T Martinez-Rincón
S Mendez-Martínez
MJ Cardiel
J García-Feijoo
J Ruberte
R Herrero-Vanrell
L Pablo
E Garcia-Martin
I Bravo-Osuna
author_sort MJ Rodrigo
collection DOAJ
description Purpose To evaluate a new chronic glaucoma model produced by intracameral injection of dexamethasone-loaded poly lactic-co-glycolic acid microspheres (Dex-PLGA-Ms) over six months. Methods Healthy rats received two injections (at baseline and Week 4) of Dex-PLGA-Ms into the anterior chamber of the right eye. Clinical signs and intraocular pressure (IOP) were weekly recorded. The structure of the retina and optic nerve was in vivo evaluated using optical coherence tomography (OCT) every two weeks and functionally using dark- and light-adapted electroretinography at 0–12–24 weeks. Histological studies were also performed. Results IOP progressively increased up to hypertension (23.22 ± 3.63 mmHg) in both eyes but did so later in left eyes. OCT quantified a decrease in full-thickness retina posterior pole (R), retinal-nerve-fiber layer (RNFL), and ganglion-cell layer (GCL) thickness up to 24 weeks. Right eyes showed higher neuroretinal thickness loss up to week 8. RNFL experienced the highest percentage thickness loss at the inferior-superior axis, while in GCL the inner sectors of the horizontal axis (Nasal-Temporal) suffered the greatest decrease in thickness. Retinal ganglion cell, photoreceptor, and intermediate cell functionality decreased over time. Increased deposition of collagen IV was also found in zonular fibers and the ciliary body. Conclusions This work shows the usefulness of drug delivery systems, not to treat pathology but to induce it. Only two injections of Dex-PLGA-Ms in the anterior chamber of rat eyes were enough to progressively create ocular hypertension and subsequent functional and structural neuroretinal degeneration, at least over 6 months.
first_indexed 2024-12-20T17:06:07Z
format Article
id doaj.art-e922018f63d543ec9289e68fb4866160
institution Directory Open Access Journal
issn 1071-7544
1521-0464
language English
last_indexed 2024-12-20T17:06:07Z
publishDate 2021-01-01
publisher Taylor & Francis Group
record_format Article
series Drug Delivery
spelling doaj.art-e922018f63d543ec9289e68fb48661602022-12-21T19:32:16ZengTaylor & Francis GroupDrug Delivery1071-75441521-04642021-01-012812427244610.1080/10717544.2021.19982451998245Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheresMJ Rodrigo0D Garcia-Herranz1A Aragón-Navas2M Subias3T Martinez-Rincón4S Mendez-Martínez5MJ Cardiel6J García-Feijoo7J Ruberte8R Herrero-Vanrell9L Pablo10E Garcia-Martin11I Bravo-Osuna12Department of Ophthalmology, Miguel Servet University HospitalComplutense University of Madrid. Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of MadridComplutense University of Madrid. Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of MadridDepartment of Ophthalmology, Miguel Servet University HospitalDepartment of Ophthalmology, Miguel Servet University HospitalDepartment of Ophthalmology, Miguel Servet University HospitalMiguel Servet Ophthalmology Research Group (GIMSO), University of Zaragoza, Aragon Health Research Institute (IIS Aragon)Complutense University of Madrid. Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415. National Ocular Pathology Network (OFTARED), Carlos III Health InstituteAnimal Biotechnology and Gene Therapy Centre (CBATEG), Universitat Autònoma de BarcelonaNational Ocular Pathology Network (OFTARED), Carlos III Health InstituteDepartment of Ophthalmology, Miguel Servet University HospitalDepartment of Ophthalmology, Miguel Servet University HospitalNational Ocular Pathology Network (OFTARED), Carlos III Health InstitutePurpose To evaluate a new chronic glaucoma model produced by intracameral injection of dexamethasone-loaded poly lactic-co-glycolic acid microspheres (Dex-PLGA-Ms) over six months. Methods Healthy rats received two injections (at baseline and Week 4) of Dex-PLGA-Ms into the anterior chamber of the right eye. Clinical signs and intraocular pressure (IOP) were weekly recorded. The structure of the retina and optic nerve was in vivo evaluated using optical coherence tomography (OCT) every two weeks and functionally using dark- and light-adapted electroretinography at 0–12–24 weeks. Histological studies were also performed. Results IOP progressively increased up to hypertension (23.22 ± 3.63 mmHg) in both eyes but did so later in left eyes. OCT quantified a decrease in full-thickness retina posterior pole (R), retinal-nerve-fiber layer (RNFL), and ganglion-cell layer (GCL) thickness up to 24 weeks. Right eyes showed higher neuroretinal thickness loss up to week 8. RNFL experienced the highest percentage thickness loss at the inferior-superior axis, while in GCL the inner sectors of the horizontal axis (Nasal-Temporal) suffered the greatest decrease in thickness. Retinal ganglion cell, photoreceptor, and intermediate cell functionality decreased over time. Increased deposition of collagen IV was also found in zonular fibers and the ciliary body. Conclusions This work shows the usefulness of drug delivery systems, not to treat pathology but to induce it. Only two injections of Dex-PLGA-Ms in the anterior chamber of rat eyes were enough to progressively create ocular hypertension and subsequent functional and structural neuroretinal degeneration, at least over 6 months.http://dx.doi.org/10.1080/10717544.2021.1998245glaucomaanimal modelplga microspheresneurodegenerationdexamethasone
spellingShingle MJ Rodrigo
D Garcia-Herranz
A Aragón-Navas
M Subias
T Martinez-Rincón
S Mendez-Martínez
MJ Cardiel
J García-Feijoo
J Ruberte
R Herrero-Vanrell
L Pablo
E Garcia-Martin
I Bravo-Osuna
Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres
Drug Delivery
glaucoma
animal model
plga microspheres
neurodegeneration
dexamethasone
title Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres
title_full Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres
title_fullStr Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres
title_full_unstemmed Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres
title_short Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres
title_sort long term corticosteroid induced chronic glaucoma model produced by intracameral injection of dexamethasone loaded plga microspheres
topic glaucoma
animal model
plga microspheres
neurodegeneration
dexamethasone
url http://dx.doi.org/10.1080/10717544.2021.1998245
work_keys_str_mv AT mjrodrigo longtermcorticosteroidinducedchronicglaucomamodelproducedbyintracameralinjectionofdexamethasoneloadedplgamicrospheres
AT dgarciaherranz longtermcorticosteroidinducedchronicglaucomamodelproducedbyintracameralinjectionofdexamethasoneloadedplgamicrospheres
AT aaragonnavas longtermcorticosteroidinducedchronicglaucomamodelproducedbyintracameralinjectionofdexamethasoneloadedplgamicrospheres
AT msubias longtermcorticosteroidinducedchronicglaucomamodelproducedbyintracameralinjectionofdexamethasoneloadedplgamicrospheres
AT tmartinezrincon longtermcorticosteroidinducedchronicglaucomamodelproducedbyintracameralinjectionofdexamethasoneloadedplgamicrospheres
AT smendezmartinez longtermcorticosteroidinducedchronicglaucomamodelproducedbyintracameralinjectionofdexamethasoneloadedplgamicrospheres
AT mjcardiel longtermcorticosteroidinducedchronicglaucomamodelproducedbyintracameralinjectionofdexamethasoneloadedplgamicrospheres
AT jgarciafeijoo longtermcorticosteroidinducedchronicglaucomamodelproducedbyintracameralinjectionofdexamethasoneloadedplgamicrospheres
AT jruberte longtermcorticosteroidinducedchronicglaucomamodelproducedbyintracameralinjectionofdexamethasoneloadedplgamicrospheres
AT rherrerovanrell longtermcorticosteroidinducedchronicglaucomamodelproducedbyintracameralinjectionofdexamethasoneloadedplgamicrospheres
AT lpablo longtermcorticosteroidinducedchronicglaucomamodelproducedbyintracameralinjectionofdexamethasoneloadedplgamicrospheres
AT egarciamartin longtermcorticosteroidinducedchronicglaucomamodelproducedbyintracameralinjectionofdexamethasoneloadedplgamicrospheres
AT ibravoosuna longtermcorticosteroidinducedchronicglaucomamodelproducedbyintracameralinjectionofdexamethasoneloadedplgamicrospheres